Skip to content
Screener

Abbott ABT Q2 2025 earnings

Reported July 17, 2025 · Before market open

Revenue$11.1BBeat by $50.1M
EPS$1.26In line
Revenue estimate$11.1B
EPS estimate$1.26

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$13.0B
EPS estimate$1.42

Financials

Q2 2025

Income statement

See full
Revenue$11.1B+7.4%
Gross profit$6.3B+8.9%
Operating income$2.1B+22.9%
Net income$1.8B+36.6%
EPS (diluted)$1.01+36.5%

Balance sheet

See full
Cash & equivalents$7.0B-0.5%
Total debt$13.4B-8.9%
Total equity$50.6B+28.6%
Total assets$84.0B+15.0%

Cash flow

See full
Operating cash flow$2.0B+4.4%
CapEx$502.0M-5.8%
Free cash flow$1.5B+8.3%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$240.24B+32.9%
Enterprise value$246.72B+30.9%
P/E17.2×-15.3×
P/S5.6×+1.1×

Profitability

See full
Gross margin56%+0.8pp
Operating margin17.4%+1.5pp
Net margin32.4%+18.8pp
FCF margin15.7%+1.8pp

Returns & leverage

See full
Return on equity31.1%+16.6pp
Debt / equity0.3×-0.1×
Current ratio1.8×+0.1×

Segments

By segment

See full
Medical Devices$5.4B+13.4%
Nutritional Products$2.2B+2.9%
Diagnostic Products$2.2B-1.0%
Established Pharmaceuticals$1.4B+6.9%

FAQ

When did Abbott report Q2 2025 earnings?
Abbott (ABT) reported Q2 2025 earnings on July 17, 2025 before market open.
What were Abbott's Q2 2025 revenue and EPS?
Abbott reported revenue of $11.1B and eps of $1.26 for Q2 2025.
Did Abbott beat estimates in Q2 2025?
Revenue beat the consensus estimate of $11.1B by $50.1M. EPS beat the consensus estimate of $1.26 by $0.00.
How did Abbott's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.4% from $10.4B a year earlier and eps grew 10.5% from $1.14.
Where can I find Abbott's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-035135) and the 10-Q periodic report (0001628280-25-036720) directly on SEC EDGAR. The filing index links above go to sec.gov.